Camosunate Paediatric Powder – For Infants 0-11 Months
Effective Treatment for Uncomplicated Malaria in Infants
Camosunate Paediatric Powder is a combination antimalarial medication specifically formulated for infants aged 0 to 11 months. It contains Artesunate (25 mg) and Amodiaquine (75 mg) per sachet, providing a potent treatment against Plasmodium falciparum malaria.
Key Features
Artemisinin-Based Combination Therapy (ACT): Combines Artesunate and Amodiaquine, as recommended by the World Health Organization (WHO) for effective malaria treatment.
Infant-Specific Dosage: Each sachet is precisely dosed for infants, ensuring safety and efficacy.
Easy Administration: Powder formulation allows for simple preparation and administration to young children.
Indications
- Treatment of Uncomplicated Malaria: Effective against P. falciparum, including strains resistant to other antimalarial drugs.
Dosage and Administration
Dosage: Administer one sachet daily for three consecutive days.
Preparation: Dissolve the contents of one sachet in a small amount of clean water or milk to create a suspension.
Administration: Ensure the child consumes the entire prepared dose immediately after preparation.
Completion of Therapy: It is crucial to complete the full three-day course, even if symptoms improve earlier, to ensure the elimination of the malaria parasite.
Precautions
Medical Supervision: Use under the guidance of a healthcare professional.
Allergies: Do not use if the infant has known hypersensitivity to Artesunate, Amodiaquine, or any other components of the medication.
Liver and Kidney Function: Caution is advised in infants with liver or kidney impairments; consult a healthcare provider before use.
Side Effects: Common side effects may include nausea, vomiting, or mild dizziness. Seek medical attention if severe reactions occur.
Storage
Store in a cool, dry place away from direct sunlight.
Keep out of reach of children.
Note: Always consult a healthcare professional before administering any medication to ensure it is appropriate for the child's health condition.
Camosunate Paediatric Powder offers a reliable and convenient solution for treating uncomplicated malaria in infants, aligning with WHO recommendations for artemisinin-based combination therapies.